Societe BIC (BICEY)
OTHER OTC:BICEY
Top Page
Societe BIC
(OTC:BICEY)
Select Model
Select Model
Rating:64Neutral
Price Target:
$33.00
â–²(7.63% Upside)
Action:DowngradedDate:02/26/26
The score is primarily supported by a strong financial foundation (low leverage and resilient free cash flow) and management’s guidance for stabilization with slight margin improvement. It is held back by the latest-year earnings and organic sales declines, a relatively high P/E despite those pressures, and technical signals that are positive but close to overbought.
Positive Factors
Balance Sheet Strength
Société BIC's low leverage and conservative balance sheet provide durable financial flexibility. With modest debt ratios, the company can absorb near-term earnings volatility, fund targeted buybacks/dividends, and invest in sourcing or local production to offset structural headwinds without immediate refinancing risk.
Negative Factors
Organic Revenue Decline
A multi-percentage organic sales decline signals durable demand weakness or market share erosion across core categories. Persistent organic contraction constrains operating leverage, limits pricing power, and makes margin recovery harder unless product mix improvement or distribution wins are sustained over subsequent quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance Sheet Strength
Société BIC's low leverage and conservative balance sheet provide durable financial flexibility. With modest debt ratios, the company can absorb near-term earnings volatility, fund targeted buybacks/dividends, and invest in sourcing or local production to offset structural headwinds without immediate refinancing risk.
Read all positive factors
Societe BIC (BICEY) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$2.43B
Dividend Yield8.92%
Average Volume (3M)160.00
Price to Earnings (P/E)26.3
Beta (1Y)0.48
Revenue Growth-3.58%
EPS Growth-16.42%
CountryUS
Employees10,192
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)0.14
Shares Outstanding81,722,626
10 Day Avg. Volume265
30 Day Avg. Volume160
Financial Highlights & Ratios
PEG Ratio-0.43
Price to Book (P/B)1.30
Price to Sales (P/S)1.08
P/FCF Ratio10.17
Enterprise Value/Market Cap0.82
Enterprise Value/Revenue0.95
Enterprise Value/Gross Profit1.85
Enterprise Value/Ebitda7.53
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Societe BIC Business Overview & Revenue Model
Company Description
Société BIC SA manufactures and sells stationery, lighter, shaver, and other products worldwide. It offers ball and coloring felt pens, markers, sticky notes, leads, whiteboards, and correction tapes, as well as graphite, coloring, mechanical, and...
How the Company Makes Money
BIC generates revenue primarily through the sale of its core products in the stationery, lighters, and shavers segments. The company operates on a business-to-consumer model, selling its products through various retail channels, including supermar...
Societe BIC Earnings Call Summary
Earnings Call Date:Feb 24, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:Apr 28, 2026
Earnings Call Sentiment Neutral
The call was mixed. BIC reported meaningful top-line and margin pressures for 2025 (organic sales down 4.7%, adjusted EBIT margin down 2.0 percentage points) and incurred substantial one-off charges and tariff headwinds. However, management highlighted clear stabilization in H2 and Q4, resilient free cash flow (EUR 222m), successful integration and strong growth from Tangle Teezer (double-digit growth, +4.1 points to group growth), tangible product and ESG progress, and a committed capital return policy. The company positions 2026 as a transitional year with an expectation of improving organic trends and slight margin expansion driven by portfolio simplification and cost discipline.Positive Updates
Stabilized Sales and H2 Improvement
Full year net sales of EUR 2.1 billion (down 0.9% at constant currency) with improved momentum in H2 and Q4 net sales of EUR 495 million (up 1.1% at constant currency). Management highlighted stabilization and modest second-half growth after a weak first half.
Negative Updates
Organic Revenue Decline and Earnings Pressure
Net sales down 4.7% on an organic basis for the full year, adjusted EPS fell to EUR 4.74 from EUR 6.15 in 2024, adjusted EBIT down EUR 60 million year-on-year, and adjusted net income group share down to EUR 195 million from EUR 256 million.
Read all updates
Q4-2025 Updates
Positive
Negative
Stabilized Sales and H2 Improvement
Full year net sales of EUR 2.1 billion (down 0.9% at constant currency) with improved momentum in H2 and Q4 net sales of EUR 495 million (up 1.1% at constant currency). Management highlighted stabilization and modest second-half growth after a weak first half.
Read all positive updates
Company Guidance
Management guided that 2026 will focus on improving organic net sales trends (they will now report on organic net sales as the key KPI) while targeting a slight expansion in adjusted EBIT margin versus 2025’s 13.6% (down 2.0 pts from 15.6% in 2024) and stable free cash flow year‑on‑year versus the EUR222m generated in 2025; they expect Q1 to be roughly flat on an organic basis, will continue to offset an estimated EUR31m annual U.S. tariff impact (EUR13m hit in 2025 with ~EUR18m remaining), and plan to return capital via a proposed ordinary dividend of EUR2.40 (50.6% payout) plus a share buyback program up to EUR40m—while noting that 2025 included EUR127m of non‑recurring items (EUR104m for discontinued Skin Creative/Rocketbook, EUR11m on Cello, EUR10m PPA adjustments) and that accretive contributors like Tangle Teezer (double‑digit growth and +4.1 pts to group growth) should support margin and sales improvement.Societe BIC Financial Statement Overview
Summary
Income Statement
54
Neutral
Balance Sheet
76
Positive
Cash Flow
71
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.01B | 2.20B | 2.26B | 2.23B | 1.83B |
| Gross Profit | 978.78M | 1.19B | 1.15B | 1.08B | 930.75M |
| EBITDA | 264.15M | 424.52M | 442.92M | 401.94M | 563.32M |
| Net Income | 82.61M | 212.01M | 226.51M | 198.60M | 314.19M |
Balance Sheet | |||||
| Total Assets | 2.61B | 2.83B | 2.65B | 2.69B | 2.50B |
| Cash, Cash Equivalents and Short-Term Investments | 478.80M | 459.17M | 477.26M | 422.86M | 468.91M |
| Total Debt | 317.86M | 334.90M | 156.19M | 119.38M | 100.07M |
| Total Liabilities | 947.60M | 1.04B | 800.74M | 820.38M | 772.02M |
| Stockholders Equity | 1.66B | 1.79B | 1.85B | 1.87B | 1.72B |
Cash Flow | |||||
| Free Cash Flow | 213.24M | 270.59M | 258.97M | 216.40M | 214.38M |
| Operating Cash Flow | 296.80M | 357.71M | 353.30M | 299.99M | 280.56M |
| Investing Cash Flow | -57.63M | -283.71M | -114.06M | -172.46M | 57.57M |
| Financing Cash Flow | -214.20M | -73.26M | -192.06M | -175.18M | -148.27M |
Societe BIC Technical Analysis
Negative
30.66
Price Trends
31.75
Negative
30.08
Positive
30.59
Negative
Market Momentum
-0.48
Positive
41.74
Neutral
14.41
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BICEY, the sentiment is Negative. The current price of 30.66 is below the 20-day moving average (MA) of 30.88, below the 50-day MA of 31.75, and above the 200-day MA of 30.59, indicating a bearish trend. The MACD of -0.48 indicates Positive momentum. The RSI at 41.74 is Neutral, neither overbought nor oversold. The STOCH value of 14.41 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BICEY.
Societe BIC Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $22.22B | 27.62 | 17.16% | 1.38% | 1.45% | 42.04% | |
68 Neutral | $1.72B | 12.42 | 5.52% | 3.15% | -5.21% | 1.96% | |
64 Neutral | $2.43B | 26.25 | 5.14% | 8.92% | -3.58% | -16.42% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | $12.80B | 19.52 | 1502.49% | 5.05% | -9.35% | 123.06% | |
52 Neutral | $916.11M | -3.02 | 1.62% | 3.51% | -1.34% | -73.59% | |
49 Neutral | $1.50B | -5.46 | -10.89% | 7.76% | -5.88% | 90.23% |
* Consumer Defensive Sector Average
BICEY
Societe BIC
30.33
-1.16
-3.68%
CHD
Church & Dwight
93.87
-9.52
-9.20%
CLX
Clorox
103.07
-33.11
-24.31%
NWL
Newell Brands
3.55
-2.65
-42.71%
SPB
Spectrum Brands Holdings
74.22
6.53
9.65%
EPC
Edgewell Personal Care
19.61
-8.92
-31.26%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.